Latest Updates:

vonLanthen Group Annual Connected Health Devices Summit


Berlin, April 21 - 22, 2016


Peter Haug, Head of Business Development & Licensing of oncgnostics GmbH:


"Innovative MDx for Early and Reliable Detection of Cervical Cancer"


40min Case Study Presentation and Panel Discussion


Conference Brochure Annual Connected Health Devices Summit
160421 Berlin HD PRINT.pdf
Adobe Acrobat Dokument 1.7 MB

March 16, 2016:


Career Talks BIGS Neuroscience Bonn

International representatives from different fields:

Academic Teaching: Geert Ramakers – Utrecht University
Pharmaceutical Industry: Isabelle Niespodziany – UCB Pharma S.A.
Government: Marlies Dorlöchter – DLR Project Management Agency – Health Research
Start-ups: Peter Haug – Founding Angels
Scientific Journalism & Filmmaking: Pia Grzesiak – Grzesiak Films


Further Details



December 2015:


Molecular diagnostics company oncgnostics GmbH wins Life Sciences Award at European Venture Summit 2015 in Düsseldorf


Award Winners E-Unlimited Homepage

Life Sciences Award Winners 2015, left: Peter Haug, Head of Business Development & Licensing oncgnostics GmbH

E-Unlimited Press Release European Venture Summit 2015 Award Winners
PR EVS Award Winners.pdf
Adobe Acrobat Dokument 173.5 KB

September 2015:


Molecular diagnostics company oncgnostics GmbH submitted CE-IVD marking for its early and reliable cervical cancer test GynTect®


GynTect German Press Release

GynTect English Press Release
Adobe Acrobat Dokument 71.8 KB

Business Coaching Science4Life July 2015 (Sulfotools,start: 0:58min):

Presentations by Peter Haug in May & June 2015:

January 2015:

Molecular diagnostics company oncgnostics GmbH closes Series A financing round for CE mark and market entry of its cervical cancer diagnostics test


Press Release HTGF

German Press Release

Portfolio of Lead-Investor bm-t

November 2014:

Thüringer Innovationspreis - oncgnostics wins special distinction for young companies, endowed with 20,000 €


Report in Thüringer Allgemeine Zeitung

Video ( Link ):

November 2014:

CyberChampions Awards - 300Microns wins INIT Innovation Price, endowed with 5,000 €


Video ( Link ):

September 2014: Article on Company Foundation/ KIT Spin Off in Nachrichten aus der Chemie ( 300Microns )


July 2014:

Founding Angel Overview:

Founding Angels help bridging the technology transfer gap between academic research and industrial applications via set up of technological-oriented start-up companies.


Dr. Peter Haug is specialized in developing start-up companies in chemistry, cleantech & biotech and pharma segments. As part of ongoing Founding Angel activities he was CEO of a Cleantech start-up company and has built up the following start-up ventures:

  • AViSpectro (Pharma/ Cleantech)

Please see how we support founding start-up companies and technology transfer in Chemistry, Cleantech, Biotech and Pharma together with

  • Researchers & Head of Research Organizations
  • Graduates and Students interested in start-up companies
  • Technology Transfer Organizations


As partner and accredited coach of various technology transfer organizations we can also initially support start up projects. This often is an ideal solution for initial market evaluation or first discussions with potential customers within our network - in a non-binding manner for the technical founding team and the Founding Angel, giving an impression of a subsequent co-operation to all involved parties.


We are co-operating with various technology transfer offices of leading research organizations and are looking forward to your message.